Medicine

Validation of IHC4 + C for male breast cancer

Carmen C. van der Pol, A. D. de Hond, Dieuwke Mink van der Molen, Quirine Manson, I. Borel-Rinkes, A. Witkamp, E. van der Wall, H. Verkooijen, P. V. van Diest

2026.1.23VIRCHOWS ARCHIV

DOI: 10.1007/s00428-025-04386-x

tlooto Summary

The IHC4 + C algorithm that was originally developed for FBC patients performed well in an MBC cohort and accurately separated patients with good, intermediate, and poor performance at high statistical significance.

Abstract

Abstract is not available.

Citation format

POL, Carmen C. van der, et al. Validation of IHC4 + c for male breast cancer. VIRCHOWS ARCHIV, 2026, 488(5): 1049–1057.